Tahan, V. Et Al. 2009. Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?. Hepato-gastroenterology , vol.56, no.94-95 , 1425-8.

Tahan, V., Ozaras, R., Karaca, C., Uraz, S., Eren, F., Danalioglu, A., ... Avsar, E.(2009). Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?. Hepato-gastroenterology , vol.56, no.94-95, 1425-8.

Tahan, Veysel Et Al. "Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?," Hepato-gastroenterology , vol.56, no.94-95, 1425-8, 2009

Tahan, Veysel Et Al. "Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?." Hepato-gastroenterology , vol.56, no.94-95, pp.1425-8, 2009

Tahan, V. Et Al. (2009) . "Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?." Hepato-gastroenterology , vol.56, no.94-95, pp.1425-8.

@article{article, author={Veysel Tahan Et Al. }, title={Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?}, journal={Hepato-gastroenterology}, year=2009, pages={1425-8} }